Biodistribution, tumor detection, and radiation dosimetry of 18F-DCFBC, a low-molecular-weight inhibitor of prostate-specific membrane antigen, in patients with …

SY Cho, KL Gage, RC Mease… - Journal of Nuclear …, 2012 - Soc Nuclear Med
Prostate-specific membrane antigen (PSMA) is a type II integral membrane protein
expressed on the surface of prostate cancer (PCa) cells, particularly in androgen …

Biodistribution, tumor detection, and radiation dosimetry of 18F-DCFBC, a low-molecular-weight inhibitor of prostate-specific membrane antigen, in patients with …

SY Cho, KL Gage, RC Mease… - Journal of Nuclear …, 2012 - europepmc.org
Methods Five patients with radiologic evidence of metastatic PCa were studied after the
intravenous administration of 370 MBq (10 mCi) of (18) F-DCFBC. Serial PET was …

[HTML][HTML] Biodistribution, Tumor Detection, and Radiation Dosimetry of 18F-DCFBC, a Low-Molecular-Weight Inhibitor of Prostate-Specific Membrane Antigen, in …

SY Cho, KL Gage, RC Mease… - Journal of nuclear …, 2012 - ncbi.nlm.nih.gov
Prostate-specific membrane antigen (PSMA) is a type II integral membrane protein
expressed on the surface of prostate cancer (PCa) cells, particularly in androgen …

Biodistribution, tumor detection, and radiation dosimetry of 18F-DCFBC, a low-molecular-weight inhibitor of prostate-specific membrane antigen, in patients with …

SY Cho, KL Gage, RC Mease… - Journal of nuclear …, 2012 - pubmed.ncbi.nlm.nih.gov
Prostate-specific membrane antigen (PSMA) is a type II integral membrane protein
expressed on the surface of prostate cancer (PCa) cells, particularly in androgen …

Biodistribution, Tumor Detection, and Radiation Dosimetry of^ sup 18^ F-DCFBC, a Low-Molecular-Weight Inhibitor of Prostate-Specific Membrane Antigen, in Patients …

SY Cho, KL Gage, RC Mease… - The Journal of …, 2012 - search.proquest.com
Prostate-specific membrane antigen (PSMA) is a type II integral membrane protein
expressed on the surface of prostate cancer (PCa) cells, particularly in androgen …

Biodistribution, tumor detection, and radiation dosimetry of 18F-DCFBC, a low-molecular-weight inhibitor of prostate-specific membrane antigen, in patients with …

SY Cho, KL Gage, RC Mease… - Journal of …, 2012 - utsouthwestern.elsevierpure.com
Prostate-specific membrane antigen (PSMA) is a type II integral membrane protein
expressed on the surface of prostate cancer (PCa) cells, particularly in androgen …

[PDF][PDF] Biodistribution, Tumor Detection, and Radiation Dosimetry of 18F-DCFBC, a Low-Molecular-Weight Inhibitor of Prostate-Specific Membrane Antigen, in Patients …

SY Cho, KL Gage, RC Mease, S Senthamizhchelvan… - J Nucl Med, 2012 - academia.edu
MATERIALS AND METHODS Supplemental Materials and Methods as well as Results are
available online only at http://jnm. snmjournals. org. Chemistry 2-[3-(1-Carboxy-2-mercapto …

Biodistribution, tumor detection, and radiation dosimetry of 18F-DCFBC, a low-molecular-weight inhibitor of prostate-specific membrane antigen, in patients with …

SY Cho, KL Gage, RC Mease… - Journal of Nuclear …, 2012 - pure.johnshopkins.edu
Prostate-specific membrane antigen (PSMA) is a type II integral membrane protein
expressed on the surface of prostate cancer (PCa) cells, particularly in androgen …

[PDF][PDF] Biodistribution, Tumor Detection, and Radiation Dosimetry of 18F-DCFBC, a Low-Molecular-Weight Inhibitor of Prostate-Specific Membrane Antigen, in Patients …

SY Cho, KL Gage, RC Mease, S Senthamizhchelvan… - J Nucl …, 2012 - Soc Nuclear Med
MATERIALS AND METHODS Supplemental Materials and Methods as well as Results are
available online only at http://jnm. snmjournals. org. Chemistry 2-[3-(1-Carboxy-2-mercapto …

[引用][C] Biodistribution, Tumor Detection, and Radiation Dosimetry of 18F-DCFBC, a Low-Molecular-Weight Inhibitor of Prostate-Specific Membrane Antigen, in …

SY Cho, KL Gage, RC Mease… - Journal of Nuclear …, 2012 - cir.nii.ac.jp
Biodistribution, Tumor Detection, and Radiation Dosimetry of <sup>18</sup>F-DCFBC, a
Low-Molecular-Weight Inhibitor of Prostate-Specific Membrane Antigen, in Patients with …